ON January 23, 2020, the pharmaceutical giant Moderna and the Coalition for Epidemic Preparedness (CEPI) signed a $1million funding agreement to begin manufacturing a Covid-19 vaccine.
In an associated press release, Dr Richard Hatchett, CEPI’s Chief Executive Officer stated: ‘CEPI has moved with great urgency and in coordination with WHO [World Health Organisation], who is leading the development of a coordinated international response, to promote the development of new vaccines against the emerging threat of nCoV-2019.’
